Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2024 27.90M
June 30, 2024 35.22M
March 31, 2024 37.60M
December 31, 2023 45.75M
September 30, 2023 49.05M
June 30, 2023 56.28M
March 31, 2023 64.34M
December 31, 2022 71.92M
September 30, 2022 63.81M
June 30, 2022 91.26M
March 31, 2022 112.54M
December 31, 2021 128.88M
September 30, 2021 149.17M
June 30, 2021 140.55M
March 31, 2021 58.30M
December 31, 2020 70.22M
September 30, 2020 80.57M
June 30, 2020 90.08M
March 31, 2020 90.30M
December 31, 2019 105.66M
September 30, 2019 65.50M
June 30, 2019 80.31M
Date Value
March 31, 2019 91.11M
December 31, 2018 106.29M
September 30, 2018 119.19M
June 30, 2018 26.44M
March 31, 2018 36.43M
December 31, 2017 47.22M
September 30, 2017 38.58M
June 30, 2017 42.08M
March 31, 2017 48.88M
December 31, 2016 56.17M
September 30, 2016 68.92M
June 30, 2016 78.90M
March 31, 2016 90.89M
December 31, 2015 98.18M
September 30, 2015 107.60M
June 30, 2015 114.00M
March 31, 2015 119.05M
December 31, 2014 133.04M
September 30, 2014 141.10M
June 30, 2014 46.42M
December 31, 2013 -0.1229M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

27.90M
Minimum
Sep 2024
149.17M
Maximum
Sep 2021
78.47M
Average
71.07M
Median

Shareholders Equity (Quarterly) Benchmarks

uniQure NV 55.82M
Merus NV 703.26M
argenx SE --
Pharming Group 225.79M
Pharvaris NV 331.48M

Shareholders Equity (Quarterly) Related Metrics